PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Centre for Kode Technology Innovation, School of Engineering, Computer and Mathematical Sciences, Faculty of Design and Creative Technologies, Auckland University of Technology, Auckland, New Zealand.\', \'Department of Transfusion Medicine, NIH Clinical Center, National Institutes of Health, Bethesda, Maryland, USA.\', \'Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Moscow, Russia.\', \'Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Moscow, Russia.\', \'School of Science, Faculty of Health and Environmental Sciences, Auckland University of Technology, Auckland, New Zealand.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1111/trf.16327
?:doi
?:hasPublicationType
?:journal
  • Transfusion
is ?:pmid of
?:pmid
?:pmid
  • 33590501
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.645
?:rankingScore_hIndex
  • 120
?:title
  • COVID-19 antibody screening with SARS-CoV-2 red cell kodecytes using routine serologic diagnostic platforms.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all